Gần 30 công ty dược tham gia sản xuất thuốc điều trị COVID-19 giá rẻ
Medicines Patent Pool (MPP), một cơ quan của Liên hợp quốc, và công ty dược phẩm Merck & Co's (Mỹ) đã đạt thỏa thuận cho phép gần 30 công ty dược tham gia sản xuất molnupiravir, thuốc điều trị COVID-19 dạng viên của Merck, phiên bản giá thành thấp dành cho các nước nghèo hơn, nhờ đó mở rộng cơ hội cho thêm nhiều nước tiếp cận loại thuốc này.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu